Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to Engage Medical Affairs

Engagement with Medical Affairs is critical at every juncture in the drug development process, with Medical Affairs acting as a key liaison between internal stakeholders, a new generation of physicians, and patient advocates...
Read More

Top Stories

Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Health Literacy Month

Celebrating Health Literacy Month 2024:

October is Health Literacy Month, a reminder of the...
world patient safety day

Celebrating World Patient Safety Day 2024:

On World Patient Safety Day 2024, we focus on the critical...

Transforming Scientific Content with Microsoft 365 Copilot: Cactus Life Sciences in the Spotlight

We are thrilled to announce that Cactus Life Sciences has been featured in Microsoft Stories...
Omnichannel

The Quest for Omnichannel: Is Medical Affairs Ready?

Commercial and Medical Affairs must partner with each other to achieve the real benefits of...
Artificial Intelligence and Writing

Breaking Barriers: Exploring the Power of AI and NLP in Scientific Communication

Learn how medical publication professionals and medical affairs teams can embrace AI and NLP tools...
people-forming-a-chain

Why Is It Important to Include Patients as Peer Reviewers

Patient peer reviews offer an amazing opportunity to see how HCPs and pharmaceutical companies are...
Data-driven QMS Alignment-Feature image for the 30-sec video reel - AMDS

Medical Device Manufacturing: Risk-Based QMS Alignment for EU MDR

The latest EU-MDR guidelines are a step in the right direction, moving from a focus...

Beyond Words: How Voice, Graphics, and Video Are Changing the Way Researchers Reach Audiences

The growth and adoption of the internet and mobile technology have provided publishers and authors...

Learn more ABOUT our company.